1DOECKE C J, COSH D G, GALLUS A S. Standardised initial warfarin treatment evaluation of initial treatment respose and maintemance dose prediction by randomise trial, and risk factors for an excessive warfarin response[J]. Aust NZ J Med, 1991,21 (1) :319 -
2FALKRH. Atrial fibrillation[J]. N Engl J Med,2001,344(14):1 067- 1 076.
3ROUTLEGE P A, DAVIES D M, BELL S M, et al. Predicting patients' warfarin requirements[J]. lancet, 1977,11: 854 - 855.
4FENNERTY A, DOLBEN J, THOMAS P, et al. Flexible induction dose regimen for warfarin and prediction of maintenace dose[J]. Br Med J 1984,288(5):1 268-1 270.
5ROBERTSGW,GALLUSAS, DRUSKERTT, etal. Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol[ J ]. Aust NZ J Med, 1999,29( 1 ): 731 - 739.
6CROWTHER M A, GINSBERG J B, KEARON C, et al. A randomized trial comparing 5 - mg and 10- mg warfarin loading doses[J]. Arch Intern Med, 1999,159(1):46-48.
7SHAPIRO S S.Treating thrombosis in the 21st century[J]. N Engl J Med,2003,349(18): 1 762- 1 764.
8European Atrial Fibrillation Trial study Group. Optimal oral anticoagdant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemic[J]. N Engl J Med, 1995,335(1):5- 10.
9FIHN S D.Aiming for safe anticoagulation[J]. N Engl J Med, 1995,333(1) :54 - 58.
10JOHNSTON S C.Transient ischemic attack[J]. N Engl J Med, 2002,347(21) :1 687- 1 692.
